Beyond the Abstract - Treatment of prostate carcinoma with (Galectin-3)-targeted HPMA copolymer-(G3-C12)-5-Fluorouracil conjugates, by Yuan Huang, et al.

Published on 06 June 2012

BERKELEY, CA (UroToday.com) - Prostate carcinoma is one of the leading causes of cancer-related deaths, mainly owing to its metastasis to distant tissues such as the bone, lung and liver.

To read more, a FREE Urotoday registration is required. Click here to register or login above.
To read UIJ content, a separate subscription is required.

Tags:

Advanced Prostate Cancer

Beyond the Abstract

Investigative Urology

Comments (0)

Only registered users can write comments!